Back to Search
MELISSA SCHIFF, M.D.
M.D.
Specialist
NPI: 1649264409Individual
Specialties, Licenses & Credentials
Nephrology Physician
Internal Medicine — Nephrology
Code: 207RN0300X
142875(NY)
SpecialistPrimary
Specialist
Code: 174400000X
NY142875(NY)
Research & Publications (20)
NCAM and polysialyltransferase profiles match dopaminergic marker gene expression but polysialic acid is dispensable for development of the midbrain dopamine system.
PMID 19619134·J Neurochem·2009
4-observational
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.
PMID 16439435·Ann Rheum Dis·2006
8-other
Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease.
PMID 19361758·Biol Blood Marrow Transplant·2009
3-trial
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial.
PMID 19074911·Ann Rheum Dis·2009
3-trial
Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study.
PMID 19242930·Hum Mutat·2009
8-other
Identifying previous sports injury among high school athletes.
PMID 19171912·Clin Pediatr (Phila)·2009
8-other
Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data.
PMID 19074177·Ann Rheum Dis·2009
3-trial
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial.
PMID 19015207·Ann Rheum Dis·2009
3-trial
Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
PMID 19228659·J Rheumatol·2009
2-rct
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
PMID 19235592·Cancer Invest·2009
3-trial
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
PMID 18490431·Ann Rheum Dis·2009
4-observational
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
PMID 19678751·Curr Med Res Opin·2009
3-trial
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
PMID 18701556·Ann Rheum Dis·2009
2-rct
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
PMID 18576334·Arthritis Rheum·2008
4-observational
Severe neurological crisis in a patient with hereditary tyrosinaemia type I after interruption of NTBC treatment.
PMID 18500574·J Inherit Metab Dis·2008
5-case
Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis.
PMID 18056755·Ann Rheum Dis·2008
4-observational
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.
PMID 18055472·Ann Rheum Dis·2008
3-trial
Risk factors for recurrent shoulder dystocia, Washington state, 1987-2004.
PMID 18279836·Am J Obstet Gynecol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE
ROCHESTER, NY 14642 - Phone
- (585) 275-4517
Quick Facts
- NPI
- 1649264409
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile